FDA Approved: VOLTAREN ARTHRITIS PAIN — Supplemental Application (Haleon US Holdings LLC)

View source ↗

Summary

FDA approves a supplemental application for Voltaren Arthritis Pain (diclofenac sodium) by Haleon US Holdings LLC, updating its labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• Voltaren Arthritis Pain (Diclofenac sodium)

Snippet

SUPPL AP for VOLTAREN ARTHRITIS PAIN (DICLOFENAC SODIUM)